Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Plans FDA Presence In China Next Month

This article was originally published in PharmAsia News

Executive Summary

The top U.S. health official says the FDA plans to locate personnel in China beginning in May, subject to approval by Chinese authorities. Health and Human Services Secretary Mike Leavitt said in an interview in Singapore the first U.S. FDA office in China will be headed by the current director of the HHS Asia and the Pacific office, Christopher Hickey. Hickey said the FDA is still awaiting final approval from China for an FDA office there. Leavitt said FDA presence would allow not only inspections, but an ability to build capacity and maintain relationships with China's regulators. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068223

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel